APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,584	2,049	1,642	1,204	822.86
Other Revenue	-	16.62	8.49	11.55	5.82
Revenue	2,584	2,066	1,650	1,216	828.69
Revenue Growth (YoY)	25.08%	25.18%	35.71%	46.74%	72.85%
Cost of Revenue	-	579.89	486.14	354.04	259.08
Gross Profit	2,584	1,486	1,164	861.98	569.61
Selling, General & Admin	-	464.34	386.96	307.57	251.43
Research & Development	-	290.54	237.92	174.88	134.88
Other Operating Expenses	1,640	15.22	14.52	13.75	8.14
Operating Expenses	1,640	772.32	639.21	496.99	393.93
Operating Income	943.93	713.59	524.86	364.99	175.68
Interest Expense	-	-2.01	-3.69	-1.45	-1.63
Interest & Investment Income	-	25.23	27.74	23.94	13.26
Currency Exchange Gain (Loss)	-	2.83	2.66	1.17	-1
Other Non Operating Income (Expenses)	-7.64	-0.82	-0.04	-0.49	-0.5
EBT Excluding Unusual Items	936.29	738.83	551.53	388.16	185.81
Impairment of Goodwill	-	-	-3.84	-	-
Gain (Loss) on Sale of Investments	-	-16.7	-	0.34	21.72
Gain (Loss) on Sale of Assets	-	0.25	11.97	0.06	0.02
Asset Writedown	-	-0.83	-0.12	-10.68	-3.57
Other Unusual Items	-	24.42	36.83	17.25	17.58
Pretax Income	936.29	745.97	596.37	395.13	221.55
Income Tax Expense	115.65	87.8	74.24	54.98	26.7
Earnings From Continuing Operations	820.64	658.17	522.13	340.16	194.85
Minority Interest in Earnings	-	14.98	11.79	17.86	13.07
Net Income	820.64	673.15	533.92	358.02	207.92
Net Income to Common	820.64	673.15	533.92	358.02	207.92
Net Income Growth	21.91%	26.08%	49.13%	72.19%	87.70%
Shares Outstanding (Basic)	141	140	140	140	137
Shares Outstanding (Diluted)	141	141	142	142	138
Shares Change (YoY)	-0.03%	-0.52%	-0.16%	2.99%	31.45%
EPS (Basic)	5.82	4.80	3.82	2.56	1.52
EPS (Diluted)	5.82	4.77	3.77	2.52	1.51
EPS Growth	21.95%	26.74%	49.38%	67.20%	42.79%
Free Cash Flow	-	93.15	487.03	224.25	14.01
Free Cash Flow Per Share	-	0.66	3.44	1.58	0.10
Dividend Per Share	-	1.207	0.951	0.785	0.476
Dividend Growth	-	26.88%	21.20%	65.01%	100.00%
Gross Margin	100.00%	71.93%	70.54%	70.88%	68.74%
Operating Margin	36.53%	34.54%	31.81%	30.01%	21.20%
Profit Margin	31.76%	32.58%	32.36%	29.44%	25.09%
Free Cash Flow Margin	-	4.51%	29.51%	18.44%	1.69%
EBITDA	1,021	790.25	580.9	405.69	203.49
EBITDA Margin	39.50%	38.25%	35.20%	33.36%	24.56%
D&A For EBITDA	76.66	76.66	56.04	40.7	27.81
EBIT	943.93	713.59	524.86	364.99	175.68
EBIT Margin	36.53%	34.54%	31.80%	30.01%	21.20%
Effective Tax Rate	12.35%	11.77%	12.45%	13.91%	12.05%
Revenue as Reported	-	2,066	1,650	1,216	828.69

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.